U.S. Food, 2022-11-07: FDA warning letter to a Minnesota clinic that sold 'Fenbendazole Starter Pack #1' and 'Panacur-C Fenbendazole' online with cancer claims, including an explicit appeal to Joe Tippens' story. FDA treats the products as unapproved new drugs because they are intended for treating cancer in people.
On your webpage titled, 'Fenbendazole Starter Pack #1': – 'Fenbendazole… is fast becoming a successful anticancer treatment in many late-stage cancers in humans due to the experience of Joe Tippens over at MyCancerStory.rocks.'
U.S. Food, 2022-11-07: FDA warning letter to a Minnesota clinic that sold 'Fenbendazole Starter Pack #1' and 'Panacur-C Fenbendazole' online with cancer claims, including an explicit appeal to Joe Tippens' story. FDA treats the products as unapproved new drugs because they are intended for treating cancer in people. US federal enforcement record (public domain). The letter lists the products for which the clinic took orders (Fenbendazole Starter Pack #1, Panacur-C Fenbendazole, Breast Cancer Prevention Protocol Bundle, and supplements) and quotes the website's cancer claims as evidence of intended drug use. This is the clearest federal document showing fenbendazole being sold to humans as a cancer treatment in the US, and it names the Tippens story as the source of the claim. No study. The ellipsis inside the quotation is in FDA's own text (the agency elided words when quoting the website); it is not an editorial splice by this record. Also filed as FBA-44 (claims C7, C9). Study type: regulatory record.
